Meta Ads for Cannabis Brands & Dispensaries

Note: This page is educational. Platform rules change, enforcement is inconsistent, and cannabis rules vary by market. Always review Meta’s current advertising rules and local regulations before launch.

Definition: Meta Ads for Cannabis

What’s possible on Meta (realistically)

Most cannabis businesses approach Meta the wrong way. They start by asking what they can advertise. I think the better question is what role they want Meta to play in the business.

One thing I've noticed is that operators often judge Meta using the same expectations they use for Google. They want direct intent. They want immediate conversion signals. They want a clear line between the ad and the sale. Sometimes that happens. Most of the time, especially in cannabis advertising, the customer journey is much messier than that.

A person might see an ad today, search the brand next week, visit the website later, ask a friend about it, and eventually walk into the store a month from now. Meta influenced the decision, but it may never get obvious credit for it.

That is one reason cannabis businesses either overvalue Meta or undervalue it. They are measuring it against a buying journey that rarely exists in the real world.

The businesses that tend to do best on Meta usually understand this early. They use the platform to build familiarity, stay visible, educate the market, and create repeated exposure.

Then they let search, direct traffic, referrals, email, local visibility, or the store experience help move the customer toward a decision.

That doesn't mean Meta cannot generate leads, appointments, or customers. It can. But the businesses that get the most from it are usually the ones who stop trying to make Meta behave like every other advertising channel and start using it for what it is actually good at. When campaigns start running across multiple audiences, creatives, landing pages, and compliance requirements, many operators find that working with a specialized cannabis advertising agency becomes less about launching ads and more about keeping the entire paid media system stable.

Compliant campaign categories that can work

• Education-first content promotion: beginner guides, regulated buying education, safe-use explainers, terpene education, product-format education, or “what to expect” content without pushing a sale.
• Brand and store trust: store environment, staff knowledge, community presence, retail experience, quality standards, and brand familiarity without product claims.
• Store discovery: location, hours, directions, parking, pickup process, and “find a store” messaging that does not read like “order cannabis now.”
• Medical evaluation funnels where legal: eligibility education, appointment booking, patient process, evaluation pricing, and documentation guidance with conservative claims.
• Ancillary or cannabis-adjacent offers: events, software, logistics, accessories, education, or B2B services where the ad is not promoting the use or purchase of controlled products.

Ad formats that tend to be safer for cannabis advertisers

Format matters because Meta does not only read your words. It reads the pattern. A clean static creative can be easier to tolerate than a loud product-style Reel. A carousel that teaches process can survive longer than one that looks like a product shelf.

• Short educational video: simple “how it works” or “what to know before visiting” content without product visuals.
• Carousel education: 3 to 5 cards explaining steps, safety, store process, or clinic eligibility.
• Static brand creative: one clear message, light copy, no product glamor shots, no smoke, no price hooks.
• Lead forms with caution: more useful for clinics, events, and education offers than direct retail intent.
• Retargeting content: often more durable than cold hard-conversion campaigns because the user has already engaged with a safer first touch.

Examples of compliant ad angles

These angles are not magic words. They work only when the ad, landing page, and follow-up path all tell the same story. If the ad says “learn,” but the page opens with a menu, Meta can connect the dots.

Account hygiene that prevents surprise shutdowns

Meta Ads for cannabis are not just a creative problem. They are an account durability problem. A clean Business Manager, verified domain, consistent business details, and slower launch pacing can matter as much as the headline.

• Business verification: keep legal name, address, website, and page details consistent.
• Domain verification: verify the destination domain and avoid switching URLs every time an ad gets nervous.
• Pixel and Conversions API: track clean events like content views, form starts, bookings, calls, and directions rather than questionable purchase proxies.
• Creative library discipline: stop re-uploading slightly edited versions of rejected assets. That can create a pattern.
• Launch pacing: smaller campaigns often hold up better than aggressive launches because sudden spend and constant edits increase review friction.
• Page discipline: avoid changing bios, category labels, destination pages, or pinned content right after launch unless there is a clear reason.

If Meta is only one piece of the paid plan, connect this page with the Google Ads for Cannabis guide and the cannabis programmatic advertising page. The goal is not to depend on one platform behaving perfectly.

What gets banned vs. what gets “quietly restricted”

Meta enforcement is not just approved or rejected. That is where a lot of cannabis advertisers get tripped up. An ad can pass review and still deliver weakly. It can spend for a few days, then slow down. It can survive until someone edits the page, changes the creative, or pushes the budget too fast.

A lot of Meta problems start after approval. The ad gets through, then CPMs rise, learning resets, delivery thins out, or one ad set stops spending while another keeps crawling. That is often a sign Meta has not fully rejected the campaign, but it also does not fully trust it.

There is a middle zone that cannabis teams need to respect. The ad is not technically banned. The account is not disabled. Nothing dramatic happens. It just gets expensive, slow, inconsistent, and hard to scale. That is still a failure mode.

Rule of thumb: if the ad and landing page together feel like they are helping someone buy restricted products, expect friction. It may not happen immediately. That is the part people underestimate.

Why accounts get flagged, restricted, or disabled

Most cannabis Meta accounts do not get flagged because of one word. They get flagged because the full pattern looks risky. The copy says one thing. The visual suggests another. The page says something else. Then the account keeps editing and resubmitting. Meta notices patterns.

Top risk triggers in plain language

• Stacked intent: words like “weed,” “THC,” “buy,” “order,” “delivery,” “deals,” and “dispensary” showing up too close together.
• Visual shortcuts: buds, smoke, vapes, joints, packaging, or anything that looks like use instead of business information.
• Destination mismatch: the ad feels educational, but the page opens with a product menu or checkout path.
• Account history: repeated disapprovals, appeals, page edits, and new versions of the same rejected idea.
• Business Manager instability: inconsistent details, unverified assets, page changes, domain changes, unclear ownership, or assets that have been passed between too many hands.
• Too much too fast: aggressive scaling, constant creative swaps, and budget jumps before Meta has built trust with the account.
• Boosted post assumptions: posts that were fine organically can still trigger review issues once paid spend is attached.

A simple approval workflow that reduces disapprovals

1. Build the landing page first. If the page is risky, the ad is already starting from a weak place.
2. Create 2 or 3 soft angles. Keep them distinct: education, store discovery, clinic process, or brand trust.
3. Launch one controlled campaign. Do not flood the account with tests on day one.
4. Leave it alone long enough to learn. Constant edits can create more review loops than the original ad.
5. Document what holds up. The creative, page, audience, and CTA combination matters.

Soft flags that show you are drifting toward restriction

• An ad is approved, but delivery is weak from the start.
• Spend stops after a landing page, page bio, or category edit.
• CPMs spike while click-through rate stays basically the same.
• Learning resets after small changes that should not have been a big deal.
• One market performs normally while another market gets expensive or inconsistent.
• Comment moderation becomes a workload because users ask product, price, or delivery questions under safe-looking ads.
• News cycles, elections, or seasonal platform pressure make review behavior feel stricter for a while.
• Rejected assets start clustering around one visual style, one landing page, or one offer angle.

For the broader breakdown of how cannabis campaigns break across channels, use Why Cannabis Ads Fail. For the compliance foundation, keep the Cannabis Advertising Compliance Guide separate so this page does not turn into a policy manual.

Compliant medical framing (what works vs. what fails)

Medical framing can be more durable on Meta, but only when it is real. A clinic campaign has a different shape than a dispensary campaign. It can talk about eligibility, evaluation steps, pricing, privacy, documentation, and what happens next. That looks more like a healthcare process and less like a retail cannabis push.

Retail dispensaries do not get that same advantage just because they use medical-sounding language. If the page still points people toward products, strains, THC percentages, discounts, or ordering, the system may treat it like retail intent anyway.

There is also a lead-quality issue here. Clinic ads can generate interest from people who are curious but not qualified, while dispensary ads can attract people who want a menu even when the ad never promised one. The follow-up process matters because Meta’s reported lead count does not tell you whether the campaign brought real patients, real store visitors, or just cheap noise.

Medical framing that tends to pass

• Process-first messaging: “How the evaluation works,” “What to expect,” “Eligibility steps,” and “Transparent pricing.”
• Neutral condition education: only where legally appropriate, with no miracle claims or guaranteed outcomes.
• Licensed credibility: doctor information, clinic details, privacy policy, contact information, and clear patient next steps.
• One conversion goal: booking an evaluation, requesting information, or starting a qualification check.
• Plain language: no hype, no “get approved today,” no wink-wink product promise after the appointment.

Medical framing that fails

• Outcome shortcuts: “Get your card fast,” “approved today,” or wording that implies a guaranteed path to cannabis.
• Health claims: treatment promises, cure language, or heavy symptom relief claims.
• Product creep: medical copy paired with product photos, THC terms, or retail menu pages.
• Weak trust signals: no physician information, unclear ownership, thin contact details, or a page that does not feel like a real clinic.

Creative guardrails: copy, visuals, CTAs

Creative is where cannabis advertisers usually get impatient. The safer ad often feels boring. That is the point. On Meta, the safest creative is rarely the flashiest creative, and boring can outperform bold if it keeps the campaign delivering.

Creative fatigue can also arrive faster than expected because cannabis audiences are often narrow, local, and already familiar with the category. When frequency climbs, performance can fall quickly. Then teams swap creative aggressively, which can trigger more reviews. That loop is common.

There is another uncomfortable part: Meta’s classifiers do not always read creative the way humans do. A wellness image, a green-heavy design, a hand holding packaging, or a lifestyle shot near cannabis language can get interpreted in ways the brand did not intend. The creative may look tasteful to the team and still trip a restricted-content pattern.

Copy guardrails

• Use brand, education, process, store information, or clinic evaluation language instead of sales language.
• Avoid stacking high-intent terms in one asset. “THC + buy + delivery” is a bad pattern.
• Use softer CTAs like “learn,” “get info,” “find a location,” “see how it works,” or “book.”
• Keep claims conservative. If you discuss product types or effects, keep it educational and avoid promises.
• Watch lead quality by angle. A soft education ad may bring cheaper leads, but not always better ones.
• For CBD, avoid turning the ad into a health-claim pitch. Claims plus cannabinoid language can become the problem.

Visual guardrails

• Use abstract visuals, brand colors, staff, store interiors, clinic-style images, or educational graphics.
• Avoid buds, joints, smoke, vapes, dab imagery, product glamor shots, or anything that looks like consumption.
• Be careful with packaging. Even harmless-looking packaging can get classified as restricted if the page reinforces cannabis intent.
• Do not assume a rejected creative is obviously “bad.” Sometimes a harmless-looking image gets caught because of the account, page, or surrounding signals.
• Keep a few plain creative versions available. When review friction rises, simple brand and education assets are often what keep the account moving.

CTA guardrails

• Use “Learn More,” “Get Info,” “Book,” “Find a Location,” or “Download Guide.”
• Avoid “Buy Now,” “Order,” “Shop,” “Delivery Today,” “Get Weed,” or deal-style CTAs.
• Keep the CTA consistent with the destination. A safe button cannot rescue a risky page.

For channel comparison and organic demand capture, see the Cannabis SEO Ultimate Guide. For deeper creative rules, the Cannabis Ad Creative Rules guide covers safer copy and visual patterns without turning this page into a creative manual.

Landing page rules for Meta compliance

Sometimes the campaign is fine and the landing page quietly becomes the problem. That is why Meta Ads for cannabis cannot be judged by the ad alone. The destination often decides whether the campaign keeps its delivery quality.

The mistake is building a soft ad and sending people to a hard retail page. Meta may approve the ad at first, then restrict delivery once the destination, user behavior, or page updates make the intent clearer.

Landing page edits are one of the easiest ways to create new friction after launch. A page that looked safe during review can become risky when someone adds a menu block, discount strip, THC wording, pop-up, product carousel, or stronger store CTA later. The ad did not change, but the destination did.

Landing pages that tend to stay healthier

• Single-topic education pages: guides, FAQs, process explainers, and “what to expect” pages.
• Store discovery pages: location finder, hours, directions, parking, contact, and in-store expectations.
• Clinic pages: appointment funnels with eligibility, documentation, privacy, and clear next steps.
• Brand trust pages: story, standards, community, store experience, or education hub content.

Landing pages that increase risk

• Product grids, strain names, THC percentages, or menus above the fold.
• Pricing banners, discount modules, cart language, or “order online” buttons.
• Popups that immediately mention THC, weed delivery, deals, or product availability.
• Pages that change often after approval, especially when the new content adds retail intent.

For deeper landing page ownership, use cannabis advertising landing pages. This page only covers the Meta-specific risk: the destination has to match what the ad promised.

Audience strategy without policy drift

Audience strategy in cannabis is easy to overthink. The harder you push buying intent, the more fragile delivery can become. Broad often works better than over-engineered targeting because it gives Meta fewer obvious signals that the campaign is chasing restricted-product buyers.

That does not mean targeting does not matter. It means the audience, creative, and landing page have to work together without screaming “cannabis transaction.” Narrow interest stacks can fatigue fast. Lookalikes can underperform if the source quality is weak. Retargeting can be useful, but only if the first touch was safe enough to build a clean pool.

Retargeting often outlasts cold conversion campaigns because it can be framed around education, store reminders, clinic questions, or brand familiarity instead of immediate purchase intent. But even retargeting can get messy if the audience pool is built from risky pages or if the follow-up creative turns too aggressive.

Safer audience approaches

• Geo plus broad: local radius or market targeting paired with education-first creative.
• Engagement retargeting: people who watched videos, engaged with posts, or visited safe educational content.
• First-party lists: where consent and local rules allow, with careful messaging and clean data handling.
• Lookalikes: from high-quality sources like appointment bookers, content readers, or store-finder users, not messy purchase proxies.
• Sequential education: softer first touch, then retargeting with store discovery or clinic process content.

Higher-risk audience behaviours

• Interest stacks that imply cannabis purchase intent paired with sales-style creative.
• Rapid audience changes after disapprovals.
• Forcing conversion campaigns before the account has clean delivery signals.
• Assuming attribution is clean. Meta can appear stronger than reality when view-through activity, organic search, direct traffic, store visits, branded search, and retargeting overlap.

Backup plans when Meta shuts you down

Assume Meta will get unstable at some point. Not because the campaign is bad. Because cannabis is a restricted category, and Meta is not built to be predictable for it.

The backup plan is not “turn on another channel someday.” It is knowing what you will do when delivery drops, the account enters review, CPMs jump, or the winning creative burns out faster than expected.

When Meta gets shaky, the worst move is usually panic-editing everything at once. That makes it harder to know what caused the issue and can create more review activity. Stabilize first. Then diagnose.

Backup plan A: reduce single-platform dependency

• Programmatic display, CTV, and OLV: useful for reach and awareness when Meta gets inconsistent. See Cannabis Programmatic Advertising.
• SEO as the compounding layer: search demand should not disappear because one paid platform got nervous. See Cannabis SEO Methodology & Tools.
• Google Ads where possible: useful in select cases with careful funnel design. See Google Ads for Cannabis.
• SEO vs paid media planning: use Cannabis SEO vs Paid Media to decide what should capture demand and what should shape it.

Backup plan B: stabilize Meta before touching everything

• Stop making edits for a short window unless something is clearly risky.
• Shift spend to the safest approved education or brand assets.
• Reduce budget pressure if scaling created review friction.
• Audit the landing page first, especially above the fold.
• Pull back from hard conversion language and rebuild around delivery continuity.
• Moderate comments because user comments can drag the conversation back into product, price, or ordering language.
• Check Business Manager health, rejected asset patterns, account quality alerts, domain status, and page-level issues before launching anything new.

Troubleshooting: when Meta says “disapproved” (and what to change first)

When an ad gets disapproved, most teams change one word and resubmit. Then they change another word. Then another. Pretty soon the account has more review activity than it needed.

Slow down. Diagnose the system in order. Meta may be reacting to the page, the image, the CTA, the account history, or the combination.

Step 1: check the landing page above the fold

Meta’s systems crawl the destination. If the first screen contains product grids, THC percentages, strain names, pricing, discount banners, “order online,” or menu-style navigation, the ad starts with a weak foundation.

• Fix: move menu content lower, remove discount banners, and make the first screen educational or store-discovery focused.
• Fix: add real business details, contact information, privacy links, regulated-market language, and clear next steps.
• Fix: use one safe conversion action like booking, store finder, guide download, or request info.

Step 2: audit creative for restricted cues

If the creative looks like cannabis consumption, product purchase, or THC promotion, the copy may not save it. Classifiers can misread visuals, especially when the page reinforces the category.

• Fix: switch to abstract visuals, staff, store interiors, educational graphics, clinic-style photography, or neutral lifestyle content.
• Fix: remove risky word clusters from image text and primary copy.
• Fix: do not keep uploading almost the same rejected asset with tiny edits.

Step 3: simplify your account behaviour

High-frequency changes can create more review friction. In cannabis, patience can be a performance lever.

• Fix: pause new launches for a short window and let approved assets gather data.
• Fix: consolidate campaigns and ad sets until delivery quality improves.
• Fix: document what passed, what spent, what stalled, and what triggered review.

Step 4: match the funnel to the promise

One of the most common quiet restriction patterns is mismatch. The ad promises education. The page pushes shopping. The ad says clinic process. The page hints at product access. The ad says store discovery. The CTA says order now. Keep the whole path honest.

Step 5: check the comments before blaming the ads manager

Comments can turn a safe ad into a messy public thread. If users ask “Do you deliver?”, “How much for gummies?”, “What strains do you have?”, or “Can I order online?”, the campaign may start attracting the exact signals you were trying to avoid. Comment moderation is not just a brand task here. It is part of keeping the ad environment clean.

Quick playbooks: retail dispensaries vs clinics vs brands

Retail dispensary playbook

• Goal: store discovery, local familiarity, and education that can support later store visits or compliant local actions.
• Best first touch: “what to expect,” beginner guides, product-format education, store hours, location, or regulated buying information.
• Best landing page: store finder, location page, or education page. Not a menu-first page.
• Best follow-up: retarget engaged users with trust, store information, FAQs, and softer visit CTAs.

Clinic and evaluation playbook

• Goal: qualified appointments, not low-quality “where can I buy?” leads.
• Best first touch: eligibility education, evaluation steps, transparent pricing, privacy, provider credibility, and what happens next.
• Best landing page: appointment funnel with trust elements, FAQs, and clear process language.
• Best follow-up: retarget with cost, timeline, requirements, documentation, and booking support.

Brand playbook

• Goal: awareness, trust, education, and retailer discovery without product claims.
• Best creative: brand story, community, quality standards, education series, behind-the-scenes content, and creator-style content that does not push consumption.
• Best landing page: about page, education hub, store locator, newsletter, or compliant resource page.

CBD brand playbook

• Goal: brand trust, education, ingredient clarity, and compliant product understanding without medical promises.
• Best first touch: what CBD is, how to read labels, quality standards, third-party testing, and responsible buying education.
• Best landing page: education hub, quality standards page, store locator, or product-information page with conservative claims.
• Watch closely: wellness claims, cannabinoid stacking, hemp flower imagery, and copy that makes CBD look like a workaround for THC promotion.

To reduce channel fragility, pair Meta with cannabis SEO for compounding search demand and programmatic for scalable reach when social delivery gets unpredictable.

KPIs that matter (not just leads)

In cannabis, Meta reporting can lie by omission. A lead can look cheap but be low quality. A campaign can look efficient but be riding retargeting. Attribution can make Meta look stronger than it really is when people also search, call, visit maps, or come back direct.

Track performance, but also track account durability. If the account cannot keep delivering, the campaign is not healthy.

Look at Meta like an operator, not just a dashboard reader. A low CPL does not mean much if half the leads are unqualified, the comments are full of product questions, the account is collecting review warnings, and the best ad stops spending every time you adjust the page.

Meta vs Google Ads vs Programmatic: choosing the mix

Meta is usually better at shaping demand than capturing hard cannabis intent. Google can capture intent in select cases, but policy friction still matters. Programmatic can provide reach and frequency when social platforms get jumpy. SEO builds the base that paid channels should not have to carry forever.

For a longer growth view, see Cannabis Retail Growth Resources.

A 30–90 day rollout plan

Days 1–14: build a survivability baseline

• Launch 1 or 2 education-first creatives and one brand trust asset.
• Use one compliant landing page with one safe CTA.
• Track approval consistency, review interruptions, spend pacing, and qualified actions.
• Avoid heavy edits unless something is clearly creating risk.
• Keep comments watched from day one, especially on boosted or engagement-heavy posts.

Days 15–45: expand carefully

• Add retargeting from video views, page engagement, safe site visitors, or clinic page visitors.
• Test a few new creatives per week, not a flood of new ads every day.
• Watch audience fatigue, CPM volatility, and comment quality.
• Improve landing page trust signals before increasing budget pressure.
• Keep CBD, clinic, retail, and brand campaigns in clean lanes so signals do not blur.

Days 46–90: build the support system

• Add programmatic support for reach, awareness, and frequency control.
• Layer in Google Ads where the market and offer allow it.
• Publish supporting SEO content so the brand captures demand after Meta introduces people to it.
• Keep a safe creative bank ready for moments when review friction increases.
• Review attribution honestly so Meta does not get over-credited for users who were already searching or ready to visit.

Compliance checklist

• Does the ad avoid direct purchase intent language like buy, order, delivery, deals, or THC sales?
• Do visuals avoid smoke, consumption, joints, vapes, buds, and product glamor shots?
• Does the landing page avoid menus, pricing, THC percentages, product grids, and cart language above the fold?
• Does the CTA match the safe promise of the ad?
• Is the Business Manager stable, verified, and consistent?
• Are you tracking delivery continuity, not just leads?
• Do you have backup channels ready before Meta becomes unstable?
• Are comments being moderated so the ad does not turn into a public product-order thread?
• Have you checked whether CBD copy, visuals, or claims are accidentally triggering cannabis-category signals?
• Do you know which creative-page-audience combinations have held up before?

Build a safe asset bank so you can keep running ads

One of the simplest ways to avoid growth stalls is to maintain a small library of low-risk assets you can use when Meta starts reviewing aggressively. Think of it as safe mode.

• 3 evergreen education creatives: beginner guide, how it works, safety, regulated buying, or clinic process.
• 2 brand trust creatives: store experience, community presence, staff knowledge, or quality standards without product claims.
• 1 store discovery creative: hours, location, directions, or what to expect in-store.
• 1 clinic process creative: eligibility, evaluation steps, documentation, and booking expectations if applicable.
• 1 plain CBD education creative: label reading, testing standards, or ingredient transparency without health claims.

When disapprovals spike or delivery thins out, pause experimental ads and move budget toward assets with the cleanest history. Then fix the real issue, which is usually the destination, the visual cue, the CTA, or the account behavior around resubmissions.

Pro tip: document the combinations that held up: creative, page, audience, CTA, budget pace, comments, and account status. In cannabis, repeatability beats novelty more often than people want to admit.

A grounded closing note before you spend harder

If Meta keeps becoming unstable, the issue may not be budget. It may be the lane. It may be the page. It may be the comments. It may be the creative pattern. It may be that the campaign is trying to make Meta do direct-response cannabis retail when the platform is only tolerating education, trust, and softer discovery.

Before increasing spend, understand what the platform is actually tolerating. Then build around that. The campaign that keeps running is usually more valuable than the campaign everyone liked in the meeting.

FAQs: Meta Ads for Cannabis

Can dispensaries run Meta ads?

Sometimes, but not in the normal retail way most dispensaries want. If the campaign is really about products, menus, prices, THC, or ordering, it is fragile. Store discovery, education, brand trust, and softer retargeting usually have a better chance of holding up.

Does approval mean a cannabis Meta ad is safe?

No. This is where people get burned. Approval means the ad passed a review moment. It does not mean the campaign will spend well, avoid future review, survive page edits, or scale without friction.

What gets cannabis ads banned on Facebook and Instagram?

The obvious stuff is buy-now language, THC terms, consumption imagery, product menus, discounts, and ordering paths. The less obvious issue is the whole pattern: safe-looking ad, risky page, narrow buying-intent audience, repeated edits, and account history.

Are boosted posts safer for cannabis businesses?

Not automatically. A boosted post can feel harmless because it started as organic content, but paid distribution still brings review. If the image, comments, caption, or destination starts pointing toward cannabis buying intent, the boost can create the same problems as an ad campaign.

Can CBD brands run Meta Ads more easily than THC brands?

Sometimes, but CBD is not automatically safe. CBD campaigns can still run into trouble when they lean on health claims, cannabis-style visuals, cannabinoid-heavy copy, product promises, or retail pages that look too close to THC shopping behavior.

Does medical framing make Meta ads compliant?

It can help when the business is actually a clinic or medical evaluation provider and the funnel looks like a real healthcare process. It does not help much if the page drifts into product access, guaranteed outcomes, or retail cannabis intent.

What is the safest landing page for cannabis Meta Ads?

Usually a single-purpose education, store discovery, or clinic process page. Keep menus, product grids, pricing, THC percentages, cart language, and discount banners away from the first screen. The page has to match what the ad promised.

Why did my ad get approved but barely spend?

That can happen when Meta has not fully rejected the campaign but also does not fully trust the signal. The issue may be the landing page, audience, creative cue, account history, comments, or a restricted pattern that limits delivery without a clean disapproval.

Why do comments matter on cannabis Meta Ads?

Because users can drag a safe ad into risky territory. If the comments fill up with questions about prices, strains, delivery, THC, or ordering, you now have an operational moderation problem and a messier ad environment.

What should you do if your Meta ad account gets restricted?

Do not panic-edit everything. Pause risky assets, check the landing page, review recent edits, look at rejected patterns, move spend to safer education or brand creative, and reduce budget pressure while you diagnose the trigger. Also make sure programmatic, SEO, and search support are not waiting until after the account is already in trouble.